Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics - PubMed (original) (raw)
Review
doi: 10.1093/carcin/bgm228. Epub 2007 Oct 17.
Affiliations
- PMID: 17942460
- DOI: 10.1093/carcin/bgm228
Review
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics
Kohzoh Imai et al. Carcinogenesis. 2008 Apr.
Abstract
DNA mismatch repair (MMR) deficiency results in a strong mutator phenotype and high-frequency microsatellite instability (MSI-H), which are the hallmarks of tumors arising within Lynch syndrome. MSI-H is characterized by length alterations within simple repeated sequences, microsatellites. Lynch syndrome is primarily due to germline mutations in one of the DNA MMR genes; mainly hMLH1 or hMSH2 and less frequently hMSH6 and rarely hPMS2. Germline hemiallelic methylation of MLH1, termed epimutation, has been reported to be a new cause of Lynch syndrome. MSI-H is also observed in approximately 15% of colorectal, gastric and endometrial cancers and in lower frequencies in a minority of other tumors, where it is associated with the hypermethylation of the promoter region of hMLH1. MSI-H underlies a distinctive tumorigenic pathway because cancers with MSI-H exhibit many differences in genotype and phenotype relative to cancers without MSI-H, irrespective of their hereditary or sporadic origins. Genetic, epigenetic and transcriptomic differences exist between cancers with and those without the MSI-H. The BRAF V600E mutation is associated with sporadic MSI-H colorectal cancers (CRCs) harboring hMLH1 methylation but not Lynch syndrome-related CRCs. The differences in genotype and phenotype between cancers with and those without MSI-H are likely to be causally linked to their differences in biological and clinical features. Therefore, the diagnosis of MSI-H in cancers is thus considered to be of increasing relevance, because MSI-H is a useful screening marker for identifying patients with Lynch syndrome, a better prognostic factor and could affect the efficacy of chemotherapy. This review addresses recent advances in the field of microsatellite instability research.
Similar articles
- [Clinical and molecular consequences of microsatellite instability in human cancers].
Hamelin R, Chalastanis A, Colas C, El Bchiri J, Mercier D, Schreurs AS, Simon V, Svrcek M, Zaanan A, Borie C, Buhard O, Capel E, Zouali H, Praz F, Muleris M, Fléjou JF, Duval A. Hamelin R, et al. Bull Cancer. 2008 Jan;95(1):121-32. doi: 10.1684/bdc.2008.0571. Bull Cancer. 2008. PMID: 18230578 Review. French. - Microsatellite instability: an update.
Yamamoto H, Imai K. Yamamoto H, et al. Arch Toxicol. 2015 Jun;89(6):899-921. doi: 10.1007/s00204-015-1474-0. Epub 2015 Feb 22. Arch Toxicol. 2015. PMID: 25701956 Review. - Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
Svrcek M, El-Bchiri J, Chalastanis A, Capel E, Dumont S, Buhard O, Oliveira C, Seruca R, Bossard C, Mosnier JF, Berger F, Leteurtre E, Lavergne-Slove A, Chenard MP, Hamelin R, Cosnes J, Beaugerie L, Tiret E, Duval A, Fléjou JF. Svrcek M, et al. J Clin Oncol. 2007 Sep 20;25(27):4231-8. doi: 10.1200/JCO.2007.10.9744. J Clin Oncol. 2007. PMID: 17878476 - The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.
Woerner SM, Kloor M, Schwitalle Y, Youmans H, Doeberitz Mv, Gebert J, Dihlmann S. Woerner SM, et al. Genes Chromosomes Cancer. 2007 Dec;46(12):1080-9. doi: 10.1002/gcc.20493. Genes Chromosomes Cancer. 2007. PMID: 17726700 - Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
Ferreira AM, Westers H, Sousa S, Wu Y, Niessen RC, Olderode-Berends M, van der Sluis T, Reuvekamp PT, Seruca R, Kleibeuker JH, Hollema H, Sijmons RH, Hofstra RM. Ferreira AM, et al. J Pathol. 2009 Sep;219(1):96-102. doi: 10.1002/path.2573. J Pathol. 2009. PMID: 19521971
Cited by
- Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma.
Santos JC, Bastos AU, Cerutti JM, Ribeiro ML. Santos JC, et al. BMC Cancer. 2013 Feb 15;13:79. doi: 10.1186/1471-2407-13-79. BMC Cancer. 2013. PMID: 23414134 Free PMC article. - Biology of colorectal cancer.
Arvelo F, Sojo F, Cotte C. Arvelo F, et al. Ecancermedicalscience. 2015 Apr 9;9:520. doi: 10.3332/ecancer.2015.520. eCollection 2015. Ecancermedicalscience. 2015. PMID: 25932044 Free PMC article. Review. - Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer.
Yan ZH, Cui LH, Wang XH, Li C, He X. Yan ZH, et al. World J Gastroenterol. 2014 Dec 28;20(48):18338-45. doi: 10.3748/wjg.v20.i48.18338. World J Gastroenterol. 2014. PMID: 25561800 Free PMC article. - Clinical and molecular detection of inherited colorectal cancers in northeast Italy: a first prospective study of incidence of Lynch syndrome and MUTYH-related colorectal cancer in Italy.
Urso E, Agostini M, Pucciarelli S, Rugge M, Bertorelle R, Maretto I, Bedin C, D'Angelo E, Mescoli C, Zorzi M, Viel A, Bruttocao G, Ferraro B, Erroi F, Contin P, De Salvo GL, Nitti D. Urso E, et al. Tumour Biol. 2012 Jun;33(3):857-64. doi: 10.1007/s13277-011-0312-0. Epub 2012 Jan 26. Tumour Biol. 2012. PMID: 22278153 - Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific Sequencing.
Kenyon J, Nickel-Meester G, Qing Y, Santos-Guasch G, Drake E, PingfuFu, Sun S, Bai X, Wald D, Arts E, Gerson SL. Kenyon J, et al. Int J Stem Cell Res Ther. 2016;3(2):031. doi: 10.23937/2469-570x/1410031. Epub 2016 May 24. Int J Stem Cell Res Ther. 2016. PMID: 27570841 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials